Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |